Bernard GIlly is the founder of BrainEver. BrainEver has raised $33M in total funding. Latest round: Series B. Based in Paris, France.
Bernard Gilly is the co-founder and CEO of BrainEver, a biopharmaceutical company specializing in therapies for neurodegenerative diseases. He also serves as CEO of Ibionext. Gilly is associated with BrainEver's Series B financing and clinical development plans.
Full founder directory · Investor directory · Company funding database · Fundraising library